Sunshine Biopharma News

Sunshine Biopharma | 8-K: Current report

Apr 1 14:32 ET

Sunshine Biopharma | 10-K: Annual report

Mar 28 16:10 ET

Sunshine Biopharma | DEF 14C: Definitive information statements

Mar 15 11:16 ET

Sunshine Biopharma | 8-K: Current report

Mar 6 16:12 ET

Sunshine Biopharma | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition

Mar 5 16:43 ET

Sunshine Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Slilaty Steve N.

Mar 5 16:10 ET

Sunshine Biopharma | DEF 14C: Definitive information statements

Mar 5 11:40 ET

Sunshine Biopharma | 8-K: Current report

Mar 1 16:25 ET

Sunshine Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-L1 Capital Global Opportunities Master Fund, Ltd.(5.3%)

Feb 23 16:06 ET

Sunshine Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(9.99%),Altium Growth Fund, LP EIN:(9.99%), etc.

Feb 21 16:32 ET

Sunshine Biopharma | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition

Feb 21 08:26 ET

Sunshine Biopharma | 8-K: Current report

Feb 16 17:03 ET

Sunshine Biopharma | 8-K: Current report

Feb 15 11:42 ET

Sunshine Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(7.60%),Steven Boyd(7.60%)

Feb 14 15:57 ET

Sunshine Biopharma | 424B4: Prospectus

Feb 14 11:22 ET

Sunshine Biopharma | EFFECT: Others

Feb 13 06:04 ET

Sunshine Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Slilaty Steve N.

Feb 12 16:14 ET

Sunshine Biopharma | 8-K: Current report

Feb 12 09:09 ET

Sunshine Biopharma | CORRESP: CORRESP

Feb 9 22:19 ET

Sunshine Biopharma | CORRESP: CORRESP

Feb 9 22:19 ET